This is why a buyout + royalties should totally be considered.
if it eventuates that everything goes to plan, I doubt that any big pharma could afford to pay what bisantrene is worth.
alternatively, we just have to accept a new blockbuster record(tongue in cheek).
I feel it is very tight manoeuvring Race to get to that point before a big pharma takes notice though.
MST valuation of RAC, page-41
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.69 |
Change
0.000(0.00%) |
Mkt cap ! $288.0M | |||
| Open | High | Low | Value | Volume |
| $1.69 | $1.69 | $1.65 | $179.8K | 108.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1437 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.74 | 3313 | 1 |
View Market Depth
| Last trade - 15.58pm 03/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |